Article
[When and how to treat hepatitis B and C?].
Revue medicale suisse - 19 Jan 2005
Pache I, Hess J, Gonvers J J, Moradpour D
Abstract excerpt
The introduction of pegylated interferon-alpha (PEG-IFN-alpha) as well as lamivudine and adefovir has greatly improved the perspectives for patients with chronic hepatitis B. In addition, new nucleos(t)ide analogues are currently being evaluated and may allow the development of effective combination therapy regimens in the future. In the absence of resistance development, lamivudine reduces the risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
